[1] |
McDermott JD, Bowles DW. Epidemiology of head and neck squamous cell carcinomas: Impact on staging and prevention strategies[J]. Curr Treat Options Oncol, 2019, 20(5): 43.
doi: 10.1007/s11864-019-0650-5
|
[2] |
刘俊君, 覃浩, 李翠萍, 等. 硫酸软骨素蛋白多糖4在口腔鳞状细胞癌组织中的表达及其临床意义[J]. 广西医科大学学报, 2019, 36(1): 31-35.
|
[3] |
甘建国, 高攀, 王晓毅. 循环肿瘤细胞与口腔鳞状细胞癌相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 205-212.
|
[4] |
Shao TT, Wang GJ, Chen H, et al. Survey of miRNA-miRNA cooperative regulation principles across cancer types[J]. Brief Bioinform, 2019, 20(5): 1621-1638.
doi: 10.1093/bib/bby038
pmid: 29800060
|
[5] |
任晓彦, 谢慧静, 南欣荣. 口腔鳞状细胞癌中miRNA调控机制的研究进展[J]. 医学综述, 2021, 27(18): 3628-3633.
|
[6] |
Pan X, Zhao LW, Quan J, et al. MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients[J]. Am J Transl Res, 2019, 11(4): 2207-2218.
pmid: 31105829
|
[7] |
阿依提拉·热合麦提江, 屈园, 帕力旦·艾孜提, 等. miR-378a-3p靶向PKM2基因对食管鳞癌细胞Eca-109凋亡及能量代谢的影响[J]. 山西医科大学学报, 2020, 51(4): 283-287.
|
[8] |
Guo XB, Zhang XC, Chen P, et al. miR-378a-3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17[J]. Oncol Rep, 2019, 42(5): 1957-1971.
|
[9] |
刘郁, 耿加敏, 段绍斌. 长链非编码RNA-ATB在结直肠癌组织中表达及临床意义[J]. 中国实验诊断学, 2020, 24(2): 312-315.
|
[10] |
张闳博, 韩伟. 头颈部鳞状细胞癌中蛋白质翻译后修饰的研究进展[J]. 中华口腔医学杂志, 2020, 55(10): 789-793.
|
[11] |
蔡洁明, 杨伟明, 胡璇, 等. 长链非编码RNA HOTAIR在口腔鳞癌组织中的表达及临床意义[J]. 口腔颌面外科杂志, 2018, 28(2): 71-74.
|
[12] |
张艳, 兰霞斌, 陈超. 外泌体在口腔癌中的研究进展[J]. 肿瘤学杂志, 2020, 26(6): 487-490.
|
[13] |
To KK, Tong CW, Wu MX, et al. microRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside[J]. World J Gastroenterol, 2018, 24(27): 2949-2973.
doi: 10.3748/wjg.v24.i27.2949
URL
|
[14] |
Machado IF, Teodoro JS, Palmeira CM, et al. miR-378a: A new emerging microRNA in metabolism[J]. Cell Mol Life Sci, 2020, 77(10): 1947-1958.
doi: 10.1007/s00018-019-03375-z
pmid: 31748917
|
[15] |
Chen WN, Li XM, Wang JY, et al. miR-378a modulates macrophage phagocytosis and differentiation through targeting CD47-SIRPα axis in atherosclerosis[J]. Scand J Immunol, 2019, 90(1): e12766.
doi: 10.1111/sji.2019.90.issue-1
URL
|
[16] |
Krist B, Podkalicka P, Mucha O, et al. miR-378a influences vascularization in skeletal muscles[J]. Cardiovasc Res, 2020, 116(7): 1386-1397.
doi: 10.1093/cvr/cvz236
pmid: 31504257
|
[17] |
Xu ZH, Yao TZ, Liu W. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2[J]. Biomed Pharmacother, 2018, 107: 1410-1417.
doi: 10.1016/j.biopha.2018.08.132
URL
|
[18] |
Qian FL, Wang JH, Wang Y, et al. miR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation[J]. Clin Transl Med, 2021, 11(2): e307.
doi: 10.1002/ctm2.307
pmid: 33634974
|
[19] |
Qian JR, Zeng LF, Jiang XH, et al. Novel multiple miRNA-based signatures for predicting overall survival and recurrence-free survival of colorectal cancer patients[J]. Med Sci Monit, 2019, 25: 7258-7271.
doi: 10.12659/MSM.916948
URL
|